Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,646
Award facts
- Contract value 100% obligated
- $25,646.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,646.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 28, 2025, with an ultimate completion date of October 30, 2025, represents a purchase of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. has been registered in the System for Award Management since July 2001 and maintains a strong track record supplying the federal military medical system with a comprehensive product portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The underlying master contract, designated SPE2DR, was awarded on November 13, 2025, with a $499,999,999 ceiling value and extends through December 31, 2036, comprising a 30-month base period and three 30-month option periods. This contract structure positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to supply the full range of pharmaceutical and medical consumable requirements for Department of Defense healthcare facilities worldwide, enabling DLA to issue firm fixed-price delivery orders as needed to support recurring military medical supply demands.
Quick answers
Who was awarded contract SPE2DU26FEMMF?
SPE2DU26FEMMF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DU26FEMMF worth?
The government has obligated $25,646 on SPE2DU26FEMMF.
Is contract SPE2DU26FEMMF an order under another contract?
Yes. SPE2DU26FEMMF is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMF competed?
The extent of competition for SPE2DU26FEMMF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award